Shares of LumiraDx Limited (NASDAQ: LMDX) fell sharply in pre-market trading after the company agreed to sell its point-of-care technology platform to Roche. LumiraDx shares dipped 19.7% to $0.0517 in pre-market trading. Here are some other stocks moving in pre-market trading.
MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD – Get Free Report) was the recipient of a significant drop in short interest during the month of December. As of December 15th, there was short interest totalling 3,180,000 shares, a drop of 19.5% from the November 30th total of 3,950,000 shares. Based on an average trading volume of 855,500 shares, […]
MyMD Pharmaceuticals (MYMD) Reports Positive Results for Sarcopenia Drug streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
MyMD Pharmaceuticals Releases Positive Clinical Trial Results For Sarcopenia Treatment Drug finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.